Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc.
FDA inspection history in Burbank, California, 2023
- 1
- Warning letter
Every document, by year
- Warning letter
2023: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One warning letter, at Burbank, California.
The complete Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Burbank, California
One warning letter · 2023
Latest: Warning letter, Apr 19, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-04-19 | Warning letter Warning letter | Burbank, California | — | $99 |
FEI number 3016926047 · most recent document Apr 19, 2023
About Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc.
Has Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc.; the most recent is dated Apr 19, 2023.